Most Popular Stories
Poll
Featured Jobs
-
Nebraska Maternal Fetal Specialist/Director
StaffPointe, LLC - southeast , NE -
Connecticut Endocrinology NP
StaffPointe, LLC - northwest , CT -
Massachusetts NP or PA
StaffPointe, LLC - central, MA -
Massachusetts OBGYN
StaffPointe, LLC - near Boston , MA -
Oregon Physical Therapist - Inpatient
StaffPointe, LLC - central, OR
Events
- Fall Health IT Summit
Oct 27-28 — Los Angeles, CA - Free Webcast: Management Lessons from Mayo Clinic
Oct 30, 12pm EDT - World Health Care Congress
April 14-16, 2009 — Washington, DC
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Related Topics >> pharmacy benefit managers | express scripts | Pharmacy Benefits Management companies (PBMs) | allegations | medicine
Popular Topics
SPOTLIGHT: Settlements between PBMs, states not tough enough
June 4, 2008 — 6:59am ET
Recently, the industry has seen a string of cases in which pharmacy benefit managers have agreed to fork over settlements over allegations of bad behavior. Most recently, this includes the instance in which Express Scripts struck a $9.5 million agreement with 28 states over its attempts to steer patients into brand name drugs. However, these settlements are nowhere near tough-enough to deter erring PBMs from continuing with crooked practices, argues Los Angeles Times columnist David Lazarus. He argues that it will take "stronger medicine" to turn the industry around. Article
Be the first to comment
Related Stories
- Express Scripts pays $9.5M settlement over drug switching
- Express Scripts, CVS turn up Caremark rhetoric
- Express Scripts-CVS battle for Caremark heats up
- Insurers face tough day on Wall Street
- Fed appeals court ruling hurts PBMs
- MedCo lowers guidance for 2006
- Report claims generics could save system $20B
- Express Scripts cuts out some Pfizer drugs
- SPOTLIGHT: Express scripts broadens EDS deal
- SPOTLIGHT: Aetna numbers please Wall Street
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





